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ABSTRACT
Pancreatic differentiation 2 (PD2), a PAF (RNA Polymerase II Associated Factor) 
complex subunit, is overexpressed in pancreatic cancer cells and has demonstrated 
potential oncogenic property. Here, we report that PD2/Paf1 expression was 
restricted to acinar cells in the normal murine pancreas, but its expression increased 
in the ductal cells of Pdx1Cre; KrasG12D (KC) mouse model of pancreatic cancer with 
increasing age, showing highest expression in neoplastic ductal cells of 50 weeks 
???? ????????????????????????????????????????????????????????????????????????????
metaplastic ducts, representing intermediate structures during pancreatic acinar-
to-ductal metaplasia (ADM). Similar PD2/Paf1 expression was observed in murine 
pancreas that exhibited ADM-like histology upon cerulein challenge. In normal 
???????????????????????????????????????????????????????????????????????????????
which was later restored upon recovery of the pancreatic parenchyma. In KC mice, 
however, PD2/Paf1 mRNA level continued to decrease with progressive dysplasia 
and subsequent neoplastic transformation. Additionally, knockdown of PD2/Paf1 in 
pancreatic acinar cells resulted in the abrogation of Amylase, Elastase and Lipase 
??????????????????????????????????? ????????????????????????????????????????????
marker) transcripts. In conclusion, our studies indicate loss of PD2/Paf1 expression 
during acinar transdifferentiation in pancreatic cancer initiation and PD2/Paf1 
??????????????????????????????????????? ???????
INTRODUCTION
Pancreatic cancer (PC) is a lethal desmoplastic 
tumor with a 5-year survival rate of less than 6% [1]. 
It manifests cryptically with minimal early symptoms, 
and is compounded by a late clinical presentation and 
resistance to chemotherapy, which make this cancer a 
major challenge. Although much knowledge has been 
gained about the molecular mechanisms and genetic 
changes underlying pancreatic cancer pathogenesis, we 
have very little insight about the origin of this disease. 
Current tenet suggests ‘acinar-to-ductal metaplasia’ as 
the initiating event of pancreatic ductal adenocarcinoma. 
?????????????????????????? ???? ??????????????????????
differentiated cell type into another is characterized by 
loss of acinar cell polarity and gene signatures and gradual 
conversion of acinar structures into duct-like phenotype. 
During this process transitional metaplastic cells are 
formed, some of which ultimately produce the precursor 
PanIN lesions that predispose the pancreatic parenchyma 
to neoplastic transformation. 
One of the earliest studies demonstrating the 
plasticity of acinar cells was done by Wagner and 
colleagues, who found that transgenic mice overexpressing 
???????????????????????????????????????????????????????
trans-differentiation from acinar to ductal cells [2]. The 
trans-differentiation was accompanied by loss of acinar 
markers and gain in expression of ductal markers, and 50% 
Oncotarget4481www.impactjournals.com/oncotarget
of those mice developed dysplastic tumor lesions after 
??????????????????????????????????????????????????????
induced changes in epithelial differentiation required 
downstream Notch signaling though nestin-positive 
intermediates [3]. Interestingly, when mutated Kras, a 
common presence in pancreatic cancer, was selectively 
expressed in acinar cells driven by the Elastase promoter, 
it induced acinar to ductal metaplasia [4]. Further studies 
demonstrated that Kras and Notch signaling cooperate 
to reprogram acinar cells towards a ductal morphology 
[5].The environmental cues that trigger acinar to ductal 
metaplasia are not well-understood; however, chronic 
????????????????? ?????????????????????????????????????
to such metaplastic conversion [6], and this could explain 
the 16-fold increased risk of pancreatic adenocarcinoma in 
chronic pancreatitis patients [7-9]. A host of transcription 
factors take part in this transdifferentiation process, viz. 
??????????????????? ????? ?????????? ???????????????????
Morris et.al??????????????????????????????????????????
MMP7 signaling axis works as a critical modulator of the 
Kras-dependent metaplastic reprogramming of acinar cells 
[15, 16]. 
????????? ??? ?? ???????? ??? ???? ???? ???????????
II associated Factor (PAF) complex which is highly 
expressed in poorly differentiated PC. The PAF complex 
may play a critical role in cancer as other components of 
the PAF complex, viz. hCdc73, hLeo1, hCtr9 and hSki8, 
are aberrantly expressed in a number of cancers [17, 18]. 
PD2/Paf1, the main PAF subunit, is overexpressed in the 
poorly differentiated pancreatic cancer cell line Panc1 
??????????????????????????????????????. Further studies 
revealed that ectopic expression of PD2/Paf1 in mouse 
?????????? ????? ????? ???????? ??????????? ???????????????
with capacity to form tumors and metastatic deposits 
when implanted in athymic mice pancreas, indicating 
its oncogenic property[19]. Additionally studies from 
our laboratory demonstrated that PD2/Paf1 regulates the 
transcription of early endodermal lineage markers via its 
interaction with Oct3/4 protein to play a critical role in the 
maintenance of self-renewal and pluripotency of mouse 
embryonic stem cells [20]. In pancreatic cancer cells, PD2/
Paf1, plays a role in cell cycle regulation by modulating 
expression of cyclins A1, A2, D1, E1, B1, and Cdk1 [21]. 
Since pancreatic cancer is widely associated with loss of 
cell cycle due to deregulated expression of cyclins and 
cdks (cyclin dependent kinases), hence we anticipate that 
aberrant PD2/Paf1 might have a role in pancreatic cancer 
????????????????????????? ???????????????? ????????????
rearrangement can cause differential gene expression 
????????? ??? ???? ?????????? ??? ????????????? ????? ????
Paf1 also regulates histone methylation and chromatin 
remodeling in pancreatic cancer cells [22].
Inspired by the expressional and functional 
???????????????????????????????????????????????????????????
[23, 24], we sought to determine the expression pattern of 
PD2/Paf1 in Pdx1-Cre; KrasG12D (KC) spontaneous mouse 
model of PC. We found that in normal mice PD2/Paf1 is 
present only in pancreatic acini whereas its expression 
appears gradually in neoplastic ductal cells of KC mice 
with increasing age. PD2/Paf1 expression in KC mice 
?????????????????????????????????????????????????????????
to co-localize with the acinar and ductal cell markers. 
??????????????????????????????????????????????? ????????
the KC mice showed differential expression of PD2/Paf1. 
??????????????????????????????????????????????????????????
(which subsequently restored) of acinar PD2/Paf1 
expression in normal mice, but in KC mice, it continued 
to be ablated with progressive neoplasia. In addition, we 
noted that in pancreatic acinar cells, Amylase and CK19 
?????????????????????????????????????????????????????
which suggested that PD2/Paf1 may be involved in the 
maintenance of the terminally differentiated acinar cell 
population, and thus, act as an impediment to KrasG12D-
driven acinar cell de-differentiation and tumor initiation.
RESULTS
Expression of PD2/Paf1 in Pdx1-Cre;KrasG12D 
murine pancreatic cancer model
We have followed the Pdx1-Cre;KrasG12D (KC) 
model to study the progression of pancreatic cancer [25]. 
The KC model serves as one of the most sophisticated 
of the currently established murine models for PC, 
emulating the human form of the disease. In this model, 
mutant Kras (G12D) signaling drives a series of molecular 
and histological changes leading to the development of 
ductal adenocarcinoma, recapitulating pancreatic cancer 
disease progression. Since PD2/Paf1 was differentially 
expressed in human pancreatic cancer cells, we 
????????? ???? ??????????? ??? ???? ??????KrasG12D animals 
(positive for both KrasG12D and Pdx1-Cre) along with 
their contemporary normal littermates harboring either 
LSLKrasG12D or Pdx1-Cre at different time points during 
pancreatic cancer progression (N=8 for each time point). 
??????? ??? ????????? ??? ????????????? ????? ????? ????? ????
??????????????????????????????????????????????????????
(in replicates). Comparison of the KC mice with age-
matched littermate control mice led to the observation that 
?????????????????????????????????????? ?????????????????
weeks age appeared to have decreased in the Kras mice 
compared to the normal mice, even though that decrease 
???????????????????????????????????????????????????????????
?? ??????????? ????????? ??? ???? ??????????? ??????????? ???
?????????????????????????????????????????Kras mice 
compared to the control mice (p<0.05) (Figure 1A). 
Similar change in PD2/Paf1 expression was also observed 
in the KPC (KrasG12D/p53/Pdx1-Cre) mouse model of PC, 
????????????????????????????????????????????????????
week old KPC mice, having advanced pancreatic ductal 
Oncotarget4482www.impactjournals.com/oncotarget
adenocarcinoma (Figure S1A). 
Next, we investigated the expression of the PD2/
Paf1 protein during pancreatic cancer progression by 
???????????????????????????????????????? ??????????? ????
KC mice. Pancreatic tissues were harvested from 20, 30, 
40 and 50-week old mice bearing KrasG12D mutation, and 
also from age-matched normal mice for examining PD2/
Paf1 expression. In the normal mice, there was PD2/Paf1 
expression in the acinar cells of pancreas (Figure 1B, top 
?????????????????????????????????????????????????????????
in all age samples from the normal mice. However, in 
the KC mouse model, the PD2/Paf1 expression seemed 
to gradually appear in the ductal cells with increasing 
age of the mice. The ductal PD2/Paf1 expression pattern 
was most prominently visible in the dysplastic cancerous 
lesions of 40th and 50th week old-mice in the KC model 
(Figure 1B third and last panel). On the other hand, 
the acinar expression of PD2/Paf1 although present, 
appeared to decrease when compared to normal control 
tissues. Careful analysis of the tissues revealed that PD2/
Paf1 expression in the ducts was restricted to certain 
?????????????? ???????? ??? ????? ??????????????? ?????????????
structures were found to be metaplastic ducts representing 
intermediate structures with both acinar and ductal cell 
characteristics during the process of acinar-to-ductal 
metaplasia. We observed that PD2/Paf1 co-localized with 
Figure 1: Expression of PD2/Paf1 in Pdx1-Cre;KrasG12D murine pancreatic cancer model. (A) Bar diagram representation 
?????????????????????????????????????????????????????????????????????????????????????????????????????????????G12D (KC) pancreatic 
??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
upregulated at 30 and 40 weeks of age in KC mice compared to healthy age-matched controls. (B)???????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
??????? ?????? ???????????????????????????????????????????????????????? ????????????????????????? ??????????????????????????????????
gradually increasing ductal expression with increasing age of mice with mutant Kras expression.[scale bar = 50µm] (C) Confocal images 
????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
acinar cells show PD2/Paf1 expression while it appears in metaplastic ducts in pancreas of KC mice. (scale bar =50µm; zoom scale bar 
=20 µm)
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amylase in such ‘pseudo-ductal’ structures (Figure 1C). A 
parallel observation was made in the KPC mouse model of 
PC, where PD2/Paf1 was absent from the ducts of normal 
mice, but appeared in the metaplastic and neoplastic ductal 
cells of KPC mice with increasing age (Figure S1B). 
Expressional variations of PD2/Paf1 during 
cerulein induced pancreatic injury in normal 
versus KC mice
Treatment with cerulein, a cholecystokinin analogue 
is known to aggravate pancreatic juice secretion with 
Figure 2: PD2/Paf1 expression during cerulein induced pancreatic injury in normal versus KC mice. (A)
???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
expression under control conditions. At day 2 post injection, under cerulein induced metaplastic conversion, PD2/Paf1 expression appears 
in amylase and CK19 double positive metaplastic ducts in both normal and KC mice. However in normal mice at day 7 and 21, normal 
pancreatic parenchyma is restored with acinar cells showing robust amylase expression along with PD2/Paf1, which is further absent 
from the ducts (white arrow). In contrast, KC mice exhibited increasing dysplasia at days 7 and 21, with gradually increasing PD2/Paf1 
expression in CK19 positive ducts. (B) ?????????????????????????????????????????????????????????????????????????????????????????
treated conditions showed decrease in PD2/Paf1 transcript levels in KrasG12D ????????????????????????????????????????????????????????????
post trauma. (C) ???????????????????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????? ???????????????????????????
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????????????????????????????????????????????????????
condition is associated with a subsequent injury to the 
pancreatic parenchyma along with widespread histological 
changes representing de-differentiation of acinar cells 
into ductal phenotype, more commonly known as acinar 
to ductal metaplasia. In our study, we injected cerulein to 
both normal and KC mice at 6 weeks of age, and studied 
?????????????????????????????????????????????????????
induced ADM, from which the normal mice eventually 
recovered , but the mice containing mutant KrasG12D 
continued towards neoplastic progression (Figure S2). 
Metaplastic ducts characterized by the presence of both 
acinar marker amylase and ductal marker CK19 showed 
PD2/Paf1 expression (Figure 2A, Figure S3A), similar 
to our observation in KC mice progression model. In 
contrast, there was no PD2/Paf1 expression in the normal 
pancreatic ducts, which expressed only CK19 (Figure 
S3B). These trans-differentiating intermediate structures 
were visible 2 days after cerulein treatment in both normal 
???? ?? ??????????????????????????????????? ???????????
conversion. However, all normal mice examined either 7 
days or 21 days after cerulein treatment, were found to 
have recovered completely with characteristic normal 
pancreatic parenchyma, consisting primarily of acinar cell 
population. But cerulein treatment to the KrasG12D mice 
showed progressively increasing dysplasia; there was 
???????????????????????????????? ???????????????????????
in the day 21 mice (Figure 2A, H&E). Furthermore, 
examination of PD2/Paf1 expression in normal and KC 
mice (cerulein treated or untreated) showed abrogated 
????????? ????? ??????? ??? ??? ????? ????? ???????? ???
normal mice at various time points (Figure 2B). In the 
??????????????????????????????????????????????????????
???????????????????????????????????????????????????????????
to basal level as seen on days 7 and 21. A similar pattern is 
???????????????????????????????????????????????????????
????? ?????????? ??????? ???? ???????????? ??????? ????
then decreased as normal pancreatic histology restored 
itself (Figure 2C i). However, in case of KC mice, both 
????????????????????? ????????????????????????????????
progressively with increasing dysplasia whereas the CK19 
level remained high (Figure 2C ii). 
Cerulein treatment of pancreatic acinar cells
In order to elucidate the role of PD2/Paf1 in acinar 
to ductal metaplasia in vitro, we performed cerulein 
treatment in the 266-6 mouse pancreatic acinar cell line. 
These cells were treated with 10 nM of cerulein for 5 days 
and then allowed to recover for 3 days in 10% DMEM 
???????????????????????????????????????????????????????
????????????????????????????????????????????????????????
???? ????????? ??? ?????????? ???????? ???? ????? ???????
We observed that cerulein treatment led to a decrease in 
????? ?????? ??? ????????????? ????????????? ????????? ???
the level of CK19 gene. The levels of amylase and CK19 
genes were restored back to normal on day 8. PD2/Paf1 
expression also changed, although that did not reach 
????????????????????????????????????? ??????????????????
???????????????????????????????????????? ????????????? ????
????? ??? ???????????????? ?????? ???????? ???? ???????? ???
acinar cells. The untreated NIH3T3 cells did not show 
any amylase or CK19 expression, and cerulein treatment 
did not alter their expression either. On the other hand, 
a basal level of PD2/Paf1 expression was detectable in 
NIH3T3, which did not change due to cerulein treatment 
?????????????????????????????????????????????????????????
PD2/Paf1 expression. Confocal microscopy showed that 
cerulein treatment of 266-6 cells led to reduced amylase 
and PD2/Paf1 expressions at day3 compared to untreated 
cells (Figure 3B), which indicated an acinar-ductal switch.
Variation in acinar and ductal lineage markers 
due to knockdown of PD2/Paf1 in pancreatic 
acinar cells
In order to explore whether PD2/Paf1 directly 
participates in the process of acinar to ductal trans-
differentiation, we knocked down PD2/Paf1 in 266-6 
?????????????????????????????????????????????????????????
against mouse PD2/Paf1. PD2/Paf1 knockdown caused 
??????????????????????????????????????????????????????
in CK19 transcript (Figure 4A). This result correlated 
to what we have observed in vivo. We also investigated 
whether the downregulation of PD2/Paf1 would alter the 
expressions of other acinar and ductal lineage markers. 
????????? ?????????? ????????????? ?????????????? ????
acinar cell markers such as enzymes like Elastase and 
??????????????????????????????????????????????????????
marker CA II (Carbonic anhydrase II) expression was 
enhanced by PD2/Paf1 knockdown compared to the 
control cells. In summary, these results indicated that loss 
in PD2/Paf1 expression results in abrogation of acinar-
????????????????????????????????????????????? ??????????
the expression of ductal lineage markers.
Knockdown of PD2/Paf1 favors acinar cell 
plasticity
To delineate the role of PD2/Paf1 in pancreatic 
acinar-ductal transdifferentiation, we simultaneously 
???????????????????????? ????????????????????????????????
or scrambled control. 72 hours after the transfection and 
???????????????????????????????????????????????????????
?????????????????????????????????????????????????????????
a slight increase in ductal gene expression (CK19 and CA 
II), but this increment was more than 2-fold higher in the 
PD2/Paf1 knockdown cells (Figure 4B). The acinar cell 
marker amylase, on the other hand, was downregulated 
upon cerulein treatment as was observed before, with 
???????? ?????????? ??? ??????????? ??? ???????????????
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treated cells. These results indicate that loss of PD2/Paf1 
expression in the acinar cells favors acinar cell plasticity 
and transdifferentiation into ductal morphology via 
differential expression of critical marker genes.
PD2/Paf1 expression in ductal cells of acinar 
origin in pancreatic explant culture
According to a previously proposed model, an 
explant culture of pancreatic acinar cells from 6 week-old 
KC mice was established using collagen [26]. We observed 
???????????????????????????????????????????????????????
on day 1, which gradually converted into small duct 
like structures at day 3, and went on to form even bigger 
??????????? ??? ???? ?? ???????? ????? ??????????????????
analysis of PD2/Paf1, amylase and CK19 expression 
revealed that PD2/Paf1 is expressed in the amylase 
positive acinar clusters, but they did not express CK19 
(Figure 5B). As these mutants KrasG12D driven acinar 
cells spontaneously converted to a ductal morphology, we 
observed CK19 positive ductal cells that also expressed 
PD2/Paf1, even though at reduced levels compared to 
that in the acinar cells (Figure 5C). Thus, PD2/Paf1 was 
present both in acinar cells and in ductal cells of acinar 
origin in the explant culture.
DISCUSSION 
Metaplasia, the transformation of one tissue or cell 
type into another, is a physiological process that produces 
atypical or dysplastic terminal cells, and is relevant for 
development as well as for pathological conditions. The 
Figure 3: Cerulein treatment of pancreatic acinar cells. 
(A)?????? ?????????????????? ????????????? ???????? ?????????
???????????????????????????????????????????????????in vitro model 
of cerulein induced acinar to ductal metaplasia. 266-6 cells upon 
cerulein treatment show gradually decreased expression of 
amylase (day 3, 5) with a corresponding increase in CK19 ductal 
marker expression. However, on treatment retrieval, amylase 
and CK19 expression is restored to basal levels (day8). PD2/
????? ????? ?????? ????? ???? ????? ??????????? ?????????? ???? ???
cerulein treatment in the 266-6 cells. (B)? ??????????????????
studies show decrease in PD2/Paf1 (green) and amylase (red) 
expression on day3 of cerulein treatment compared to untreated 
cells [scale bar =20 µm].
Figure 4: Variation in acinar and ductal lineage 
markers due to knockdown of PD2/Paf1 expression in 
pancreatic acinar cells. (A) PD2/Paf1 was knocked down in 
???????????????????????????????????????? ??????????????????????
?????????????? ??????????? ???????????????????????????????????
lipase, elastase) and ductal markers (CK19, CA II) in PD2/Paf1 
??? ?????? ?????? ?????? ?????????? ???? ?????? ????? ????????? ???
PD2/Paf1 level led to abrogated expression of amylase, lipase 
and elastase with corresponding increase in CK19 and carbonic 
anhydrase (CA II) transcript levels. (B) Knockdown of PD2/Paf1 
in 266-6 cells along with simultaneous cerulein treatment showed 
that in the absence of PD2/Paf1 there was further decrease in 
amylase expression due to cerulein treatment compared to 
scramble treated cells and a similarly robust increase in ductal 
??????? ?????????? ???? ??????????????????? ?????????????????
???????? ?????? ???? ???? ?????????? ????? ?? ????????? ???????????
??????????????????????????????????????????
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stimulus for such dramatic trans-differentiation may be an 
?????????????????????????????????????????????????????????
lead to neoplastic transformation. Such appears to be the 
case of pancreatic cancer, in which there is a random 
acinar-ductal conversion in the pancreas. This acinar to 
ductal metaplasia event is held as the current model for 
?????????????????????????????????????????????????????????
studies have implicated the role of various transcription 
factors and signaling pathways in mediating this process. 
The PD2/Paf1 subunit of the PAF complex, through its 
???????????????????????????????????????????????????????
?????????????? ??????????? ???????????????????? ?????? ???
is also known to co-transcriptionally coordinate events 
?????????????????????????????????????????????????????
???????????????????????????????????????????????????????????
unique role of this novel protein PD2/Paf1 in pancreatic 
acinar to ductal metaplasia during murine pancreatic 
cancer progression.
Previous studies have shown that aberrant 
expression of different subunits of the human PAF 
complex is associated with tumorigenesis. The PD2/
Paf1 subunit which constitutes the core of this complex, 
merits particular attention as it is overexpressed in 
poorly-differentiated pancreatic cancer cell lines as well 
as in mouse xenografts. It is known to be a cell cycle 
regulatory molecule, and also known to be involved in the 
maintenance of stem cell self-renewal and pluripotency. 
Our recent study revealed that PD2/Paf1 plays an 
important role in the maintenance of self-renewal and drug 
resistance of pancreatic cancer stem cells [30]. Our current 
study revealed that PD2/Paf1 is expressed only in normal 
pancreatic acinar cells, but not in the ducts. In murine 
pancreatic cancer progression models, however, PD2/Paf1 
accumulated in the neoplastic ductal cells. Considering the 
role of PD2/Paf1 in stem cell differentiation, it is plausible 
that in the normal situation, its acinar-restricted expression 
points to a possible role of PD2/Paf1 in maintaining the 
differentiated state of acinar cells. Our observation that 
PD2/Paf1 is expressed in the metaplastic ducts implies 
its possible involvement in transdifferentiation. The 
metaplastic ducts are intermediate structures in the process 
of acinar to ductal metaplasia, which histologically look 
like acinar structures with enlarged hollow lumen and 
are characterized by presence of both the acinar marker 
Figure 5: Expressional variation of PD2/Paf1 in pancreatic explant culture. (A)????????????????????????????????????????????
culture established from 6-week old Pdx1-Cre/KrasG12D mouse at various time points. Day1 explant culture mainly represented acinar 
structures rich in dark zymogen granules that gradually transformed into smaller duct-like structures at day3 which further increased in 
size by day 5 of culture. (B) Confocal images showing PD2/Paf1(red) expression in amylase (violet) positive acinar structures, which were 
negative for CK19 ductal marker expression. (C)? ?????????????????????????????????????????????????????????????????????????????????
transdifferentiation of acinar cells.[scale bar = 20 µm]
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Amylase, and the ductal marker CK19. We observed that 
PD2/Paf1 co-localized with such dual positive trans-
differentiating tubules.
Pancreatitis is one of the major risk factors for 
pancreatic cancer. It can be induced in mice by cerulein 
injection, which induces histological changes seen in 
acinar to ductal transdifferentiation. We found that 
?????????????????????????????????????????????????????????
in the metaplastic ducts. Interestingly mouse genotype 
????????????????????????????????????????????????? ??????
mice recovered from cerulein injury after 2 days, but mice 
with mutant KrasG12D developed greater dysplasia that 
more rapidly progressed to adenocarcinoma. PD2/Paf1 
??????????? ?????????? ??? ???? ???????????? ??????? ?????
also dependent on the mice genotype. In KC mice, upon 
????????????????? ????????????? ?????????????? ??????
continuously decreased in tandem with amylase. This 
was in contrast to the restoration of PD2/Paf1 expression 
in normal mice during the recovery phase. In mouse 
embryonic stem cells, loss of PD2/Paf1 expression has 
been linked to increased differentiation potential towards 
an endodermal lineage [20]. Since in normal mice, PD2/
Paf1 is restricted only to the acinar cells, it is plausible 
that PD2/Paf1 has a similar role in the maintenance of 
acinar cell differentiated state. It appears that in normal 
animals, PD2/Paf1 helps in the recovery and restoration 
of the pancreatic parenchyma post-trauma, but in presence 
of mutant KrasG12D? ?????????? ????????????????????
PD2/Paf1 expression cannot be regained, which allows 
acinar cells to be reprogrammed into a ductal phenotype, 
predisposing them towards neoplastic transformation. 
A recent study demonstrated that the loss of 
EZH2, which is a part of polycomb repressor complex 
that catalyzes histone H3K27 methyltransferase, results 
in impaired pancreatic regeneration and accelerated 
KRasG12D???????? ?????????? ?????? ????? ?????? ??? ???? ?????
demonstration that in addition to tissue differentiation, the 
???????????????????????????????????????????????????????
repair by promoting the regenerative proliferation of 
progenitor cells, thereby preventing tumorigenesis. Loss 
of PD2/Paf1 has been shown to promote differentiation 
of mouse embryonic stem cells towards endodermal 
lineage through changes in Gata4, Gata6 and Fgf8 gene 
??????????????????????????????????????????????????????????
to increased acinar apoptosis and proliferation, acinar-
to-ductal metaplasia and adipocyte trans-differentiation 
through transcriptional regulation of digestive enzymes 
[10]. Therefore, we speculate that downregulation of 
PD2/Paf1 may also be responsible for the repair and re-
establishment of the acinar cell population following 
Figure 6: Involvement of PD2/Paf1 in pancreatic acinar-to-ductal metaplasia. Presence of mutated Kras (G12D) or cerulein 
?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
restricted to pancreatic acinar cells only, is ablated during this metaplastic conversion to facilitate downregulation of acinar cell marker 
genes (Amylase, Elastase, Lipase) with simultaneous upregulation of ductal markers (CK19,CA II). However, the PD2/Paf1 level increases 
with increasing dysplasia and eventually in neoplastic ductal cells with progressive appearance of preneoplastic PanIN lesions in the mutnat 
Kras mice. Therefore, PD2/Paf1 has a bi-phasic role during pathogenesis of pancreatic cancer, wherein its initial downregulation favors 
acinar to ductal metaplasia while elevated expression in later stages assists in disease progression.
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injury. However, the presence of Kras (G12D) mutation 
makes the pancreatic acinar cells refractory to PD2/Paf1-
mediated recovery. Since PD2/Paf1 has been shown to 
regulate H3K4 methylation status in pancreatic cancer 
cells [22], this function might account for the role of PD2/
Paf1 in maintenance of acinar cell lineage. 
Our in vivo observations were further supported 
by the in vitro studies with pancreatic acinar cells. The 
variation in expression of acinar genes such as Elastase 
and Amylase upon PD2/Paf1 downregulation in pancreatic 
acinar cells supports our hypothesis of PD2/Paf1-mediated 
regulation of acinar differentiation. Downregulation of 
acinar transcription factors such as Mist1 or upregulation 
of ductal transcription promoters such as HNF6 and 
Sox9 have been associated with promotion of acinar to 
ductal metaplasia [12, 13]. Our results suggest that PD2/
Paf1 might also play a similar role in the induction of 
acinar cell reprogramming by regulating acinar gene 
expression. Further our observations from simultaneous 
PD2/Paf1 knockdown and cerulein treatment experiments 
in pancreatic acinar cells suggest that the ablation of PD2/
Paf1 expression is not necessary but is favorable for acinar 
to ductal trans-differentiation. 
Pancreatic explant culture of acinar cells derived 
from the KC mice provided us with an excellent in vitro 
model to study spontaneous transdifferentiation of cells, 
including the acinar to ductal metaplasia. We observed 
that PD2/Paf1 was expressed in acinar cells as well as 
in acinar cell-derived ductal cells in explant culture; and 
these results support our in vivo observation. PD2/Paf1 
expression is restricted to acinar cells and its expression 
is ablated during acinar transdifferentiation, possibly 
contributing towards CK19 upregulation. PD2/Paf1 
expression appears to be retained at a low level in the 
ductal cells of acinar origin and subsequently increases 
during the later stages of pancreatic cancer progression. 
Interestingly, the appearance of PD2/Paf1 expression in 
neoplastic ductal cells as opposed to its absence from 
the normal ducts suggests that the PD2/Paf1 positive 
ducts might have an acinar lineage. Further lineage 
tracing experiments in vivo will be required to explore 
this hypothesis. The elevated expression of PD2/Paf1 in 
pancreatic cancer may suggest that it plays a biphasic 
role during pancreatic cancer progression; its initial 
downregulation allows acinar cell de-differentiation and 
in later stages its elevated expression favors pancreatic 
tumor progression.
In summary, our results show that PD2/Paf1 
expression is restricted to the pancreatic acinar 
compartment under non-pathological conditions 
??????????????????????????????????????????????????????
transformation, PD2/Paf1 expression is downregulated 
in the acinar cells with simultaneous abrogation of acinar 
cell markers, such as amylase, elastase and lipase, and 
upregulation of ductal markers, such as CK19 and CAII 
(Figure 6). This might facilitate gradual reprogramming 
of acinar cells into ductal cells and subsequently their 
neoplastic transformation. Since PD2/Paf1 high expression 
????????????????????????????????????????????????????????????
it might be a possible marker of their acinar origin.
MATERIALS AND METHODS
Cell Lines and Tissue Culture
Murine pancreatic acinar cell line 266-6 (????
2151™) was obtained from ATCC. The cells were cultured 
in DMEM media (Sigma) supplemented with 10% fetal 
bovine serum (Sigma) and 1% pencillin-streptamycin 
(100 units/ml) solution (Sigma) at 37°C and 5% CO
2
. 
Culture medium was changed every 2 days and cells were 
subcultured by trypsin-EDTA treatment.
Mouse lines
The B6.129-Krastm4Tyj (01XJ6) and B6. FVB-Tg 
(Ipf1-cre)1Tuv (01XL5) mice were obtained from the NCI 
Mouse Models of Human Cancers Consortium (MMHCC) 
(Frederick, MD, USA). These animals (LSL-KrasG12D 
and Pdx1-Cre) were crossed to remove the LSL cassette 
in order to activate KrasG12D (Pdx1-Cre???????KrasG12D) 
allele in the pancreas of the mouse. The F1 progeny was 
genotyped for Kras as well as Pdx1-Cre??????????????????
primers for Kras and Pdx1-Cre by Polymerase chain 
???????????????????????????????????????????????KrasG12D 
and Pdx1-Cre expressed the mutated KrasG12D allele in the 
????????????????????KrasG12D animals (positive for both 
Kras and Pdx1-Cre) and their contemporary littermates 
positive for either LSLKrasG12D or Pdx1-Cre were 
euthanized at 7, 10, 25, 30, 40 and 50 weeks of age (eight 
animals/group/time points). Animals were maintained 
by providing food and water ad libitum and also kept in 
a 12h dark/light condition. We have followed the U.S. 
Public Health Service guidelines for the care and use of 
laboratory animals with the approval of UNMC-IACUC. 
RNA Interference and transient transfection
???????????????????????????????????????????????
(sequence 5’- CGAGTCAAGTACTGCAATA-3)’. 
Synthetic sense and antisense oligonucleotides 
(Dharmacon, Lafayette, CO) were annealed in 100 mM 
potassium acetate, 30 mM Hepes-KOH (pH 7.4), and 2 
mM magnesium acetate for one minute at 90°C and one 
hour at 37°C, and frozen. For transient transfection, the 
????????????????????????????????????????????????????????
transfection. Following serum starvation for four hours, 
the cells were transfected using Lipofectamine 2000 
reagent (Invitrogen) using manufacturer’s protocol. Four 
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hours following transfection, the cells were replenished 
?????????????????????????????????????????????????????
isolated from the transfected cells at 48 and 72 hours post-
transfection.
RNA Isolation and QRT-PCR
?????? ???? ???? ?????????? ????? ?????? ??????
pancreatic tissue after tissue homogenization, using 
???????? ???? ?????????? ???? ?????????????? ?????? ?????????
?????????????????????????????????????????????????????
kit (Qiagen) and processed for reverse transcription. 
?????? ??????????????????????? ????? ??????? ??? ??????????
???????????????????????????????????????????????????????
??????????????????????????????????????????????????????
???? ??????????? ??? ????? ??? ???? ????????? ???????? ????????
and expressed relative to the indicated reference sample 
(average ± S.D. of triplicate reactions). The expressions of 
different acinar and ductal marker genes were compared 
between the scrambled and PD2/Paf1 knockdown 266-6 
cells by the two-tailed Student’s t-test. A p-value of <0.05 
??????????????????????????????????????????????????????????
???????????????????????????????????????????????
????????????????????? ???????????
The mice tissue slides were baked overnight at 580C 
and then dewaxed by washing in xylene solution three 
times for 10 mins each. The slides were then rehydrated 
????????????????????????????????????????????????????????
??????????????????????????????????????????????????????
methanol for 1 hour followed by antigen recovery by 
heating in 0.01M citrate buffer in a microwave for 
15mins. The tissues were then blocked with 10% normal 
goat serum and incubated with the primary antibodies - 
mouse anti-PD2/Paf1[1:100], rabbit anti-amylase [Sigma, 
??????????????????????????????????????????????????????
at 40C. PD2/Paf1 monoclonal antibody was raised in our 
lab corresponding to amino acids 327–348 peptide which 
is exactly humongous to mouse PD2/Paf1 molecule. This 
antibody has been used for the mouse ESC lines and 
NIH3T3 lines [19, 20]. After overnight incubation, the 
slides were washed with 1X PBS three times, incubated 
with secondary antibody (FITC conjugated anti-rat, Texas 
???? ??????????? ???????????? ???? ????? ??????????? ?????
mouse) for 30mins and then washed again in PBS. The 
slides were mounted by DAPI containing Vectashield 
mounting solution. The slides were analyzed using Zeiss 
(Carl Zeiss Microimaging, Thornwood, NY) confocal 
laser-scanning microscope, and representative photographs 
were captured digitally using the 710 LSM software.
Cerulein treatment in vitro and in vivo
Mice were treated with the cholecystokinin analogue 
Cerulein to induce pancreatitis following the staggered 
?????????????????????????????????????????????????????????
given 8 hourly intraperitoneal injections with cerulein 
(75µg/kg body weight) on two alternate days. Counting 
???????????????????????????????????????? ???? ??????????????
at 2, 7 and 21 days post-treatment and tissues were 
????????????????????????????????????????????????????
analysis. For cerulein treatment in vitro, 266-6 cells 
were treated with 100nM of cerulein for 5 days and then 
?????????????????????????? ???? ?????????????????????
was collected on day 1, 3, 5 and 8 and processed for real-
??????????????????
Explant Culture
Explant culture of pancreatic acinar cells from 6 
week old KrasG12D;Pdx1-Cre (KC) mice was established 
???????????????????????????????????????????????????????????
well plate was pre-coated with neutralized rat tail collagen 
???????????????????????????????????oC. 6 week-old KC 
????? ????? ?????????? ???? ????????? ???? ????????? ?????
washed in cold HBSS and subjected to digestion in 0.2mg/
ml Collagenase P solution for 10 minutes at 37oC. The 
reaction was stopped by adding cold HBSS containing 5% 
FBS and centrifuged at 720g for 2 mins at 4oC. The pellet 
was resuspended in 10ml of 5% FBS containing HBSS 
and allowed to pass through 500µm and 105µm sterile 
????????????????????????????????????????????????????????
to the top of a 30%FBS cushion and centrifuged at 180g 
for 2 mins at 4oC. The pellet was further resuspended in 10 
???????????????????? ?????????????????? ???????????????
?? ?????? ??????? ????????????? ????? ???????? ???????
solution, 100ug/ml Soybean Trypsin Inhibitor and 1ug/
ml dexamethasone. It was then mixed with equal volume 
??????????????????????????????????????????????????????
??????????????? ??????????????????????????????? ????? ???
added to each well. 
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